First Diagnosis of Immunoglobulin A Nephropathy Following SARS-CoV-2 mRNA Vaccination in

被引：3

作者：

Yokote, Shinya ^{[1
]}

Ueda, Hiroyuki ^{[2
]}

Shimizu, Akihiro ^{[3
]}

Okabe, Masahiro ^{[4
]}

Haruhara, Kotaro ^{[3
]}

Sasaki, Takaya ^{[5
]}

Aoki, Ryousuke ^{[6
]}

Joh, Kensuke ^{[7
]}

Saeki, Harumi ^{[8
]}

Tomita, Shigeki ^{[9
]}

Tsuboi, Nobuo ^{[2
]}

Suzuki, Hitoshi ^{[10
]}

Suzuki, Yusuke ^{[6
]}

Yokoo, Takashi ^{[2
]}

机构：

[1] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Katsushika Med Ctr, Tokyo, Japan

[2] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, 3-25-8 Nishi Shimbashi, Minato Ku, Tokyo 1058461, Japan

[3] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Kashiwa Hosp, Chiba, Japan

[4] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Daisan Hosp, Tokyo, Japan

[5] Kawaguchi Municipal Med Ctr, Div Nephrol, Kawaguchi, Japan

[6] Juntendo Univ, Dept Nephrol, Sch Med, Tokyo, Japan

[7] Jikei Univ, Dept Pathol, Sch Med, Tokyo, Japan

[8] Juntendo Univ, Dept Human Pathol, Sch Med, Tokyo, Japan

[9] Juntendo Univ, Dept Pathol, Urayasu Hosp, Chiba, Japan

[10] Juntendo Univ, Dept Nephrol, Urayasu Hosp, Chiba, Japan

来源：

KIDNEY INTERNATIONAL REPORTS | 2023年 / 8卷 / 01期

关键词：

gloss hematuria; IgA nephropathy; kidney biopsy; Oxford classification; SARS-CoV-2; vaccination; GROSS HEMATURIA;

D O I：

10.1016/j.ekir.2022.10.012

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The SARS-CoV-2 mRNA vaccine has been effective against COVID-19.1,2 However, following mass-scale SARS-CoV-2 mRNA vaccination, several immune-mediated disorders, including newly diag-nosed or exacerbated cases of IgA nephropathy (IgAN), have been reported worldwide.3-6Majority of the reported IgAN cases associated with SARS-CoV-2 mRNA vaccination show gross hematuria; however, the commonality in the kidney histopathological find-ings remains uncharacterized. In this study, patients first diagnosed with IgAN by kidney biopsy due to gross hematuria following SARS-CoV-2 mRNA vaccina-tion at 6 medical centers were evaluated. The details of study methods are shown in the Supplementary Methods.S1-S4

引用

页码：179 / 182

页数：4

共 9 条

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[2] Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy [J].

Bellur, Shubha S. ;

Lepeytre, Fanny ;

Vorobyeva, Olga ;

Troyanov, Stephan ;

Cook, H. Terence ;

Roberts, Ian S. D. .

KIDNEY INTERNATIONAL, 2017, 91 (01) :235-243

[3] A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study [J].

Kamano, Chisako ;

Shimizu, Akira ;

Joh, Kensuke ;

Hashiguchi, Akinori ;

Hisano, Satoshi ;

Katafuchi, Ritsuko ;

Kawamura, Tetsuya .

CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (05) :509-521

[4] Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy [J].

Kudose, Satoru ;

Friedmann, Paul ;

Albajrami, Oltjon ;

D'Agati, Vivette D. .

KIDNEY INTERNATIONAL, 2021, 100 (02) :468-469

[5] Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy [J].

Negrea, Lavinia ;

Rovin, Brad H. .

KIDNEY INTERNATIONAL, 2021, 99 (06) :1487-1487

[6] Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy [J].

Perrin, Peggy ;

Bassand, Xavier ;

Benotmane, Ilies ;

Bouvier, Nicolas .

KIDNEY INTERNATIONAL, 2021, 100 (02) :466-+

[7] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].

Polack, Fernando P. ;

Thomas, Stephen J. ;

Kitchin, Nicholas ;

Absalon, Judith ;

Gurtman, Alejandra ;

Lockhart, Stephen ;

Perez, John L. ;

Perez Marc, Gonzalo ;

Moreira, Edson D. ;

Zerbini, Cristiano ;

Bailey, Ruth ;

Swanson, Kena A. ;

Roychoudhury, Satrajit ;

Koury, Kenneth ;

Li, Ping ;

Kalina, Warren V. ;

Cooper, David ;

Frenck, Robert W., Jr. ;

Hammitt, Laura L. ;

Tureci, Ozlem ;

Nell, Haylene ;

Schaefer, Axel ;

Unal, Serhat ;

Tresnan, Dina B. ;

Mather, Susan ;

Dormitzer, Philip R. ;

Sahin, Ugur ;

Jansen, Kathrin U. ;

Gruber, William C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615

[8] A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination [J].

Rahim, Shab E. Gul ;

Lin, Jonathan T. ;

Wang, John C. .

KIDNEY INTERNATIONAL, 2021, 100 (01) :238-238

[9] Remission of proteinuria improves prognosis in IgA nephropathy [J].

Reich, Heather N. ;

Troyanov, Stephan ;

Scholey, James W. ;

Cattran, Daniel C. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (12) :3177-3183

← 1 →